
Jubilant Ingrevia Limited has informed the Exchange regarding a press release dated Jun 27, 2024, titled "Communication from United States Food and Drug Administration (USFDA)".
Filed with NSE ·

Jubilant Ingrevia Limited has informed the Exchange regarding a press release dated Jun 27, 2024, titled "Communication from United States Food and Drug Administration (USFDA)".
6ix hasn’t read this filing yet.
Follow Jubilant Ingrevia into a list and get an email when it puts out news.
Follow Jubilant Ingrevia